UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Declining costs

MMW Fortschritte der Medizin, 2016-06, Vol.158 Suppl 1, p.58-58

Neumaier, Judith

2016

Volltextzugriff (PDF)

Regress risk in aut idem prescribing

MMW Fortschritte der Medizin, 2014-08, Vol.156 (14), p.13-13

Zimmermann, Gerd W

2014

Volltextzugriff (PDF)

Medication supply of privately insured patients in 2010

Versicherungsmedizin, 2012-06, Vol.64 (2), p.85-86

Wild, Frank

2012

Volltextzugriff (PDF)

HERA-QUEST: HTA evaluation of generic pharmaceutical products to improve quality, economic efficiency, patient safety and transparency in drug product changes in hospitals

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2017-04, Vol.121, p.5-13

2017

Volltextzugriff (PDF)

Regresses for medicine prescription: benchmark evaluations should be eliminated

MMW Fortschritte der Medizin, 2013-11, Vol.155 Spec No 2, p.16-16

Dryden, Wolfgang-Axel

2013

Volltextzugriff (PDF)

Drug costs in Germany: 12 poorer countries are the benchmark

MMW Fortschritte der Medizin, 2012-11, Vol.154 (21), p.12-12

Laschet, Helmut

2012

Volltextzugriff (PDF)

Can we transfer the mechanisms of the generics market to biosimilars?

Versicherungsmedizin, 2016-12, Vol.68 (4), p.168-172

2016

Volltextzugriff (PDF)

Economic public health significance of generic drugs

Wiener Klinische Wochenschrift, 2009, Vol.121 (11-12), p.365-371

2009

Volltextzugriff (PDF)

Generics in Austria 2003-2008: an update

Wiener Klinische Wochenschrift, 2008, Vol.120 (3-4), p.61

Müller, Markus

2008

Volltextzugriff (PDF)

Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report

Nervenarzt, 2008-11, Vol.79 (11), p.1337-1345

Fritze, Jürgen

2008

Volltextzugriff (PDF)

The costs of new drugs compared to current standard treatment

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2013, Vol.107 (7), p.461-467

2013

Volltextzugriff (PDF)

Generics in psychiatry--do they have the same therapeutic equivalence as the original?

Neuropsychiatrie, 2008, Vol.22 (4), p.221-222

2008

Volltextzugriff (PDF)

Changing lamotrigine preparations in epilepsy patients. Experiences of a university epilepsy outpatient centre

Nervenarzt, 2010-04, Vol.81 (4), p.423-434

2010

Volltextzugriff (PDF)

Total savings effect up to 3 billions Euro

MMW Fortschritte der Medizin, 2006-04, Vol.148 (17), p.57

Schlander, Michael

2006

Volltextzugriff (PDF)

Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness

Deutsche medizinische Wochenschrift (1946), 2009-01, Vol.134 (5), p.181

2009

Volltextzugriff (PDF)

Interview with the Daiichi-Sankyo managing director Ralf Göddertz (interview by Dirk Einecke and Cornelius Heyer)

MMW Fortschritte der Medizin, 2013-04, Vol.155 (7), p.16

Göddertz, Ralf

2013

Volltextzugriff (PDF)

HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?

MMW Fortschritte der Medizin, 2014-06, Vol.156 Suppl 1, p.62-63

2014

Volltextzugriff (PDF)

Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors

Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)), 2012-01, Vol.74 (1), p.23

2012

Volltextzugriff (PDF)

Prescription of generic drugs to privately insured persons

Versicherungsmedizin, 2012-12, Vol.64 (4), p.190-192

Wild, Frank

2012

Volltextzugriff (PDF)

Drug treatment of cystic fibrosis - cost patterns and savings potential for outpatient treatment

Medizinische Klinik (München. 1983), 2010-12, Vol.105 (12), p.887-900

2010

Volltextzugriff (PDF)

Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report

Nervenarzt, 2006-03, Vol.77 (3), p.376-383

Fritze, Jürgen

2006

Volltextzugriff (PDF)

More and more discount contracts. A chance to be free of the budget pressure

MMW Fortschritte der Medizin, 2007-05, Vol.149 (19), p.54-55

Schmidt, Klaus

2007

Volltextzugriff (PDF)

Therapy with recombinant growth hormone

MMW Fortschritte der Medizin, 2007-06, Vol.149 (23), p.41-43

Wabitsch, Martin

2007

Volltextzugriff (PDF)

Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany

Deutsche medizinische Wochenschrift (1946), 2008-07, Vol.133 (27), p.1423

2008

Volltextzugriff (PDF)

Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts

MMW Fortschritte der Medizin, 2008-10, Vol.150 (40), p.52-53

2008

Volltextzugriff (PDF)

1 – 25 von 54

Menü

Weitere Dienste

Einstellungen

Declining costs

Regress risk in aut idem prescribing

Medication supply of privately insured patients in 2010

HERA-QUEST: HTA evaluation of generic pharmaceutical products to improve quality, economic efficiency, patient safety and transparency in drug product changes in hospitals

Regresses for medicine prescription: benchmark evaluations should be eliminated

Drug costs in Germany: 12 poorer countries are the benchmark

Can we transfer the mechanisms of the generics market to biosimilars?

Economic public health significance of generic drugs

Generics in Austria 2003-2008: an update

Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report

The costs of new drugs compared to current standard treatment

Generics in psychiatry--do they have the same therapeutic equivalence as the original?

Changing lamotrigine preparations in epilepsy patients. Experiences of a university epilepsy outpatient centre

Total savings effect up to 3 billions Euro

Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness

Interview with the Daiichi-Sankyo managing director Ralf Göddertz (interview by Dirk Einecke and Cornelius Heyer)

HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?

Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors

Prescription of generic drugs to privately insured persons

Drug treatment of cystic fibrosis - cost patterns and savings potential for outpatient treatment

Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report

More and more discount contracts. A chance to be free of the budget pressure

Therapy with recombinant growth hormone

Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany

Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts

Aktive Filter

Suchergebnisse filtern